Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jul 21;14(7):e243048.
doi: 10.1136/bcr-2021-243048.

Giant retroperitoneal lymph node-an uncommon presentation of duodenal neuroendocrine tumour

Affiliations
Case Reports

Giant retroperitoneal lymph node-an uncommon presentation of duodenal neuroendocrine tumour

Yashwant Sakaray et al. BMJ Case Rep. .

Abstract

Primary retroperitoneal neuroendocrine tumours (NETs) are extremely rare, and many a times, these are metastatic lesions with known or unknown primary location, most commonly arising from the stomach, duodenum, small intestine and rectum. NETs arising from the duodenum are more commonly seen in the first part of the duodenum followed by the second part. The incidence is increasing because of easy accessibility to endoscopies and cross-sectional imaging. In NETs, lymph node (LN) metastasis occurs commonly when the tumour size is more than 2 cm. In contrast, LN metastasis occurs even with subcentimetric lesions, especially the ampullary variant of NETs. A patient presented to us with mild abdominal pain and found to have retroduodenal mass. On evaluation found to be a metastatic LN deposit of NET with the primary arising from the first part and supra-ampullary part of duodenum.

Keywords: gastrointestinal surgery; stomach and duodenum; surgical oncology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
(A) Axial image depicting well-defined hypodense lesion retroduodenal lymph nodal mass. (B) Endoscopic view of duodenum showing submucosal lesion with central umbilication. (C) Resected specimen of the distal stomach and proximal duodenum along with lymph nodal mass. (D) Cut section resected specimen showing submucosal nodule in proximal duodenum (solid white arrow).
Figure 2
Figure 2
(A) Metastatic tumour deposits were seen in the locoregional lymph nodes dissected from the attached mesentery (200×, H&E). (B and C) The larger mesenteric mass (sent separately) showed large central areas of haemorrhage. The periphery of the mass showed preserved nodal architecture, which was largely replaced by a morphologically similar tumour (100× and 400×, H&E). (D) Inset shows the Ki67 index, which is 1%.

References

    1. Williams ED, Sandler M. The classification of carcinoid tumours. Lancet 1963;1:238–9. 10.1016/S0140-6736(63)90951-6 - DOI - PubMed
    1. Sato Y, Hashimoto S, Mizuno K-I, et al. . Management of gastric and duodenal neuroendocrine tumors. World J Gastroenterol 2016;22:6817. 10.3748/wjg.v22.i30.6817 - DOI - PMC - PubMed
    1. Modlin IM, Champaneria MC, Chan AKC, et al. . A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of NO progress. Am J Gastroenterol 2007;102:1464–73. 10.1111/j.1572-0241.2007.01185.x - DOI - PubMed
    1. Park SG, Lee BE, Kim GH, et al. . Risk factors for lymph node metastasis in duodenal neuroendocrine tumors: a retrospective, single-center study. Medicine 2019;98:e15885. 10.1097/MD.0000000000015885 - DOI - PMC - PubMed
    1. Weichert RF, Roth LM, Krementz ET, et al. . Carcinoid-islet cell tumors of the duodenum. Report of twenty-one cases. Am J Surg 1971;121:195–205. 10.1016/0002-9610(71)90098-5 - DOI - PubMed

Publication types

MeSH terms